Back to Search
CORT LAWTON, M.D.
M.D.
Orthopaedic Surgery Physician
NPI: 1255759528IndividualAccepts Medicare
Specialties, Licenses & Credentials
Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery
Code: 207X00000X
036-150085(IL)
Education
OTHER
Class of 2014
Research & Publications (20)
RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.
PMID 18947938·Int J Radiat Oncol Biol Phys·2009
8-other
Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer.
PMID 18947941·Int J Radiat Oncol Biol Phys·2009
4-observational
Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.
PMID 17881145·Int J Radiat Oncol Biol Phys·2008
3-trial
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions.
PMID 17531401·Int J Radiat Oncol Biol Phys·2007
3-trial
Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05).
PMID 17084551·Int J Radiat Oncol Biol Phys·2007
3-trial
Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.
PMID 15681524·J Clin Oncol·2005
3-trial
Hormones and radiation therapy in locally advanced adenocarcinoma of the prostate.
PMID 12728443·Semin Radiat Oncol·2003
6-review
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate.
PMID 11240234·Int J Radiat Oncol Biol Phys·2001
3-trial
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.
PMID 19394158·Int J Radiat Oncol Biol Phys·2010
6-review
Correspondence of continuous interstitial glucose measurement against arterialised and capillary glucose following an oral glucose tolerance test in healthy volunteers.
PMID 19674490·Br J Nutr·2010
8-other
Results of the Association of Directors of Radiation Oncology Programs (ADROP) survey of radiation oncology residency program directors.
PMID 19427549·Int J Radiat Oncol Biol Phys·2009
8-other
ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.
PMID 19386445·Int J Radiat Oncol Biol Phys·2009
6-review
Impairments in glucose tolerance can have a negative impact on cognitive function: a systematic research review.
PMID 19026680·Neurosci Biobehav Rev·2009
1-meta
Designing equivalent treatment regimens for prostate radiotherapy based on equivalent uniform dose.
PMID 18039721·Br J Radiol·2008
8-other
Pelvic lymph node irradiation for prostate cancer: who, why, and when?
PMID 18082586·Semin Radiat Oncol·2008
6-review
Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.
PMID 18172188·J Clin Oncol·2008
3-trial
Does timing of androgen deprivation influence radiation-induced toxicity? A secondary analysis of radiation therapy oncology group protocol 9413.
PMID 18314175·Urology·2008
8-other
Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer.
PMID 18413638·J Clin Oncol·2008
3-trial
A comparison of daily megavoltage CT and ultrasound image guided radiation therapy for prostate cancer.
PMID 19175119·Med Phys·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 650 S RANDALL RD
ALGONQUIN, IL 60102 - Phone
- (815) 398-9491
Quick Facts
- NPI
- 1255759528
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile